Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Paul Rogers et al.|Cell stem cell|2021Cited by 153
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targetingKristin M. Snyder, Bruce Walcheck, Kate Dixon et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 21
755P B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through NK cellsJeffrey S. Miller, Martin Felices, Nicholas A. Zorko et al.|Annals of Oncology|2022Cited by 9
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCCKate Dixon, Bruce Walcheck, Robert Hullsiek et al.|Blood|2020Cited by 8